Zavegepant: First Approval (vol 83, pg 825, 2023)

被引：0

作者：

Dhillon, Sohita ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901,Mairangi Bay, Auckland 0754, New Zealand

来源：

关键词：

D O I：

10.1007/s40265-023-01915-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：1

共 50 条

[21] Belumosudil: First Approval (vol 81, pg 1677, 2021)
Blair, Hannah A.
DRUGS, 2021, 81 (17) : 2075 - 2075
[22] Inclisiran: First Approval (vol 81, pg 389, 2021)
Lamb, Yvette N.
DRUGS, 2021, 81 (09) : 1129 - 1129
[23] Mavacamten: First Approval (vol 82, pg 1127, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (11) : 1235 - 1235
[24] Tegileridine: First Approval (vol 84, pg 717, 2024)
Dhillon, Sohita
DRUGS, 2024, 84 (08) : 1011 - 1011
[25] Triheptanoin: First Approval (vol 80, pg 1595, 2020)
Shirley, Matt
DRUGS, 2020, 80 (17) : 1873 - 1873
[26] Efgartigimod: First Approval (vol 82, pg 341, 2022)
Heo, Young-A
DRUGS, 2022, 82 (05) : 611 - 611
[27] Spesolimab: First Approval (vol 82, pg 1681, 2022)
Blair, Hannah A.
DRUGS, 2023, 83 (01) : 103 - 103
[28] Contezolid: First Approval (vol 81, pg 1587, 2021)
Hoy, Sheridan M.
DRUGS, 2021, 81 (16) : 1945 - 1945
[29] Vorasidenib: First Approval (vol 84, pg 1325, 2024)
Lamb, Yvette N.
DRUGS, 2024, 84 (12) : 1673 - 1673
[30] Filgotinib: First Approval (vol 80, pg 1987, 2020)
Dhillon, Sohita
Keam, Susan J.
DRUGS, 2021, 81 (02) : 297 - 297